Matches in SemOpenAlex for { <https://semopenalex.org/work/W4290830493> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W4290830493 endingPage "e2.176" @default.
- W4290830493 startingPage "e2.176" @default.
- W4290830493 abstract "Background Clinical trial populations do not fully reflect routine practice. The power of routinely collected data is increasingly recognised. Methods The OPTIMISE:MS pharmacovigilance study is a prospective, pragmatic observational study, conducted across 13 UK MS centres. Data were collected at the time of routine clinical visits. The first participant was recruited on 24th May 2019; data were extracted on 11th November 2021. Results 2112 participants were included (median age 44.0 years; 1570 (72%) female; 1981 (94%) relapsing- remitting MS). 639 (30%) were untreated at study entry, 205 (10%) taking interferon beta/copaxone, 1004 (47%) were taking second/third generation DMT first line (including dimethyl fumarate, oral cladribine, natalizumab, ocrelizumab), and 264 (13%) had escalated from either interferon beta or copaxone. 342 clinical events were reported, of which 108 were infections. There was an increased risk of adverse events in people taking second/third generation DMT (RR 3.45, 95%CI 1.57-7.60, p<0.01 vs no DMT). Unadjusted Poisson regression demonstrated increased incident adverse events in people taking natalizumab (IRR 5.28, 95%CI 1.41-19.74, p<0.05), ocrelizumab (IRR 3.24, 95%CI 1.22-8.62, p<0.05), and GA biosimilar (Brabio) (IRR 4.89, 95%CI 1.31-18.21, p<0.05) vs no DMT. Conclusions Routinely collected healthcare data can be used to evaluate DMT safety in people with MS. These data highlight the potential of pragmatic studies to guide understanding of risks and benefits associated with DMT." @default.
- W4290830493 created "2022-08-12" @default.
- W4290830493 creator A5016778416 @default.
- W4290830493 creator A5018371658 @default.
- W4290830493 creator A5049611050 @default.
- W4290830493 creator A5051820123 @default.
- W4290830493 creator A5051881912 @default.
- W4290830493 creator A5070529061 @default.
- W4290830493 creator A5087589112 @default.
- W4290830493 date "2022-08-12" @default.
- W4290830493 modified "2023-10-02" @default.
- W4290830493 title "Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)" @default.
- W4290830493 doi "https://doi.org/10.1136/jnnp-2022-abn2.30" @default.
- W4290830493 hasPublicationYear "2022" @default.
- W4290830493 type Work @default.
- W4290830493 citedByCount "0" @default.
- W4290830493 crossrefType "journal-article" @default.
- W4290830493 hasAuthorship W4290830493A5016778416 @default.
- W4290830493 hasAuthorship W4290830493A5018371658 @default.
- W4290830493 hasAuthorship W4290830493A5049611050 @default.
- W4290830493 hasAuthorship W4290830493A5051820123 @default.
- W4290830493 hasAuthorship W4290830493A5051881912 @default.
- W4290830493 hasAuthorship W4290830493A5070529061 @default.
- W4290830493 hasAuthorship W4290830493A5087589112 @default.
- W4290830493 hasBestOaLocation W42908304932 @default.
- W4290830493 hasConcept C118552586 @default.
- W4290830493 hasConcept C126322002 @default.
- W4290830493 hasConcept C197934379 @default.
- W4290830493 hasConcept C203014093 @default.
- W4290830493 hasConcept C23131810 @default.
- W4290830493 hasConcept C2776036978 @default.
- W4290830493 hasConcept C2776819417 @default.
- W4290830493 hasConcept C2778186239 @default.
- W4290830493 hasConcept C2778843634 @default.
- W4290830493 hasConcept C2779253243 @default.
- W4290830493 hasConcept C2779338263 @default.
- W4290830493 hasConcept C2780640218 @default.
- W4290830493 hasConcept C2780653079 @default.
- W4290830493 hasConcept C2781004633 @default.
- W4290830493 hasConcept C2781176495 @default.
- W4290830493 hasConcept C2908647359 @default.
- W4290830493 hasConcept C57658597 @default.
- W4290830493 hasConcept C71924100 @default.
- W4290830493 hasConcept C73269764 @default.
- W4290830493 hasConcept C99454951 @default.
- W4290830493 hasConceptScore W4290830493C118552586 @default.
- W4290830493 hasConceptScore W4290830493C126322002 @default.
- W4290830493 hasConceptScore W4290830493C197934379 @default.
- W4290830493 hasConceptScore W4290830493C203014093 @default.
- W4290830493 hasConceptScore W4290830493C23131810 @default.
- W4290830493 hasConceptScore W4290830493C2776036978 @default.
- W4290830493 hasConceptScore W4290830493C2776819417 @default.
- W4290830493 hasConceptScore W4290830493C2778186239 @default.
- W4290830493 hasConceptScore W4290830493C2778843634 @default.
- W4290830493 hasConceptScore W4290830493C2779253243 @default.
- W4290830493 hasConceptScore W4290830493C2779338263 @default.
- W4290830493 hasConceptScore W4290830493C2780640218 @default.
- W4290830493 hasConceptScore W4290830493C2780653079 @default.
- W4290830493 hasConceptScore W4290830493C2781004633 @default.
- W4290830493 hasConceptScore W4290830493C2781176495 @default.
- W4290830493 hasConceptScore W4290830493C2908647359 @default.
- W4290830493 hasConceptScore W4290830493C57658597 @default.
- W4290830493 hasConceptScore W4290830493C71924100 @default.
- W4290830493 hasConceptScore W4290830493C73269764 @default.
- W4290830493 hasConceptScore W4290830493C99454951 @default.
- W4290830493 hasIssue "9" @default.
- W4290830493 hasLocation W42908304931 @default.
- W4290830493 hasLocation W42908304932 @default.
- W4290830493 hasLocation W42908304933 @default.
- W4290830493 hasOpenAccess W4290830493 @default.
- W4290830493 hasPrimaryLocation W42908304931 @default.
- W4290830493 hasRelatedWork W1532617462 @default.
- W4290830493 hasRelatedWork W2059346471 @default.
- W4290830493 hasRelatedWork W2191040185 @default.
- W4290830493 hasRelatedWork W2789804395 @default.
- W4290830493 hasRelatedWork W2897587086 @default.
- W4290830493 hasRelatedWork W2959474424 @default.
- W4290830493 hasRelatedWork W3030177861 @default.
- W4290830493 hasRelatedWork W3115204872 @default.
- W4290830493 hasRelatedWork W4283511960 @default.
- W4290830493 hasRelatedWork W4290830493 @default.
- W4290830493 hasVolume "93" @default.
- W4290830493 isParatext "false" @default.
- W4290830493 isRetracted "false" @default.
- W4290830493 workType "article" @default.